MEDICINOVA, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
MEDICINOVA, INC. (MNOV) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $3.85 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.85K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.49K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12.29K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18.17K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $3.85K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $7.49K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $12.29K 10-K · filed 2026-03-10 |
| 2025-09-30 | $18.17K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $25.13K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $33.28K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $42.58K 10-K · filed 2025-02-19 |
| 2024-09-30 | $53.20K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $64.50K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $77.87K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $92.34K 10-K · filed 2024-02-15 |
| 2023-09-30 | $107.23K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $123.78K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $129.31K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $145.54K 10-K/A · filed 2023-03-28 |
| 2022-09-30 | $162.73K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $181.28K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $201.08K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $215.79K 10-K · filed 2022-02-16 |
| 2021-09-30 | $220.10K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $7.81K 10-K · filed 2021-02-19 |
| 2019-12-31 | $34.31K 10-K · filed 2020-02-13 |
| 2019-09-30 | $43.90K 10-Q · filed 2019-10-24 |
| 2019-06-30 | $51.76K 10-Q · filed 2019-07-25 |
| 2019-03-31 | $45.92K 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |